NCT05908682View on ClinicalTrials.gov

Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

October 31, 2029

Study Completion Date

October 31, 2029

Conditions
Vulvovaginal CandidiasisCandida InfectionVaginal Candidiasis
Interventions
OTHER

Non-interventional study

This is not an interventional study

Trial Locations (1)

110057

RECRUITING

AWINSA, New Delhi

Sponsors

Collaborators (1)

AWINSA
All Listed Sponsors
collaborator

AWINSA

UNKNOWN

lead

Scynexis, Inc.

INDUSTRY